Press Enter to Main Content
您的瀏覽器似乎不支援JavaScript語法,但沒關係,這裡的JavaScript語法並不會影響到內容的陳述, 如需要選擇字級大小,IE6請利用鍵盤按住ALT鍵+ V → X → (G)最大(L)較大(M)中(S)較小(A)小,來選擇適合您的文字大小, 而IE7或Firefox瀏覽器則可利用鍵盤 Ctrl + (+)放大(-)縮小來改變字型大小,如需要回到上一頁可使用瀏覽器提供的 Alt+左方向鍵(←) 快速鍵功能,列印可使用瀏覽器提供的(Ctrl+P)功能。
  • facebook
  • line
  • twitter
  • Print
  • Back

The 8th Joint Conference of Taiwan and Japan on Medical Products Regulation in Taipei on October 15th, 2020.

  • Data Source:Food and Drug Administration, Ministry of Health and Welfare
  • Created:2020-10-15
  • Last Updated:2020-10-15

The 8th Joint Conference of Taiwan and Japan on Medical Products Regulation this year is taking place on October 15th, 2020 at National Biotechnology Research Park in Taipei. Due to the impact of COVID-19 pandemic, this is the first time to hold the online conference with Japan side through Webex.

Since the “Framework of the Cooperation on the Medical Products Regulation” was signed by Taiwan-Japan Relations Association and Japan-Taiwan Exchange Association in November 2013, Taiwan Food and Drug Administration (TFDA) works with Japan’s Ministry of Health, Labour, and Welfare (MHLW) and Pharmaceuticals and Medical Devices Agency (PMDA) to host Annual Joint Conference in alternative turns for eight years. This year, the representatives from TFDA and MHLW and PMDA share the latest information regarding the pharmaceutical regulations, as well as other important topics such as regulatory challenge against COVID-19, recent regulatory challenge in medical devices and Quality Management System (QMS) utilization of MOC. Apart from the TFDA and MHLW and PMDA, around 200 participants from both Taiwan and Japan’s industries join the conference. The deliverables of this conference include reaching and enhancing the mutual understandings of the regulatory information and the collaborations between regulatory authority and industries.